New blood markers could spot dangerous pregnancy complication earlier

NCT ID NCT07349277

Recruiting now Diagnosis Sponsor: Ammar Jassim Abed Source: ClinicalTrials.gov ↗

First seen Jun 26, 2026 · Last updated Jun 27, 2026 · Updated 1 time

Summary

This study is testing whether three substances in the blood can help doctors diagnose and monitor preeclampsia, a serious pregnancy condition involving high blood pressure. Researchers will measure these markers in 120 pregnant women between 20 and 36 weeks. The goal is to find a more accurate way to detect preeclampsia early and track how well treatment is working.

What this could mean

Our plain-language read of the trial. This is informational only — not medical advice or a prediction.

What this could lead to: If successful, this could lead to a simple blood test to detect preeclampsia earlier and more accurately, helping doctors manage the condition.
What could go wrong: This is an early-stage study with only 120 participants. The markers may not prove reliable enough for widespread use, and results may not apply to all pregnant women.

This is an AI summary of the original study and may miss details. Read our disclaimer.

Get updates

Get notified about this study

Sign up to get updates when this study changes or when new studies for GESTATIONAL HYPERTENSION are added.

Our safety recommendation!

By submitting, you agree to our Terms of use

Conditions

The condition(s) this trial relates to.

hypertension, pregnancy-induced hypertensive disorder preeclampsia

As listed by the trial registrant

The condition terms exactly as the trial's registrant entered them.

GESTATIONAL HYPERTENSION HYPERTENSIVE DISORDERS OF PREGNANCY PREECLAMPSIA

Contacts and locations

Locations

Bint Al Huda Maternity Hospital
RECRUITING

Nasiriyah, Dhi Qar, 64001, Iraq

More trials for these conditions

Other studies related to the condition(s) this trial covers.